<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Cardiothorac Surg</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Cardiothorac Surg</journal-id>
      <journal-title-group>
        <journal-title>Journal of Cardiothoracic Surgery</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1749-8090</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23433239</article-id>
      <article-id pub-id-type="pmc">3599937</article-id>
      <article-id pub-id-type="publisher-id">1749-8090-8-29</article-id>
      <article-id pub-id-type="doi">10.1186/1749-8090-8-29</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A rare case of Candida parapsilosis endocarditis in a young healthy woman &#x2013; case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Pelemi&#x161;</surname>
            <given-names>Mijomir</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>pelemismijomir@yahoo.com</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A2">
          <name>
            <surname>Stevanovi&#x107;</surname>
            <given-names>Goran</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>goran_drste@yahoo.com</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Lavadinovi&#x107;</surname>
            <given-names>Lidija</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>lidija.lavadinovic@medfak.bg.ac</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Mati&#x107;</surname>
            <given-names>Sne&#x17E;ana</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>matic.snezana@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Milo&#x161;evi&#x107;</surname>
            <given-names>Ivana</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>ivana25@sbb.rs</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Kora&#x107;</surname>
            <given-names>Milo&#x161;</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>milos.korac@med.bg.ac.rs</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Pelemi&#x161;</surname>
            <given-names>Svetislav</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>svetislav@pelemis.com</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Nedeljkovi&#x107;</surname>
            <given-names>Milan</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>milanned@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A9">
          <name>
            <surname>Prostran</surname>
            <given-names>Milica</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>mprostran@doctor.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Clinic for Infectious and Tropical Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Bulevar oslobodjenja 16, 11000, Belgrade, Serbia</aff>
      <aff id="I2"><label>2</label>Clinic for Cardiology, Clinical Center of Serbia, Dr Koste Todorovica 8, 11000, Belgrade, Serbia</aff>
      <aff id="I3"><label>3</label>Clinic for Otorhinolaringology, Clinical Center of Serbia, Pasterova 2, 11000, Belgrade, Serbia</aff>
      <aff id="I4"><label>4</label>Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000, Belgrade, Serbia</aff>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>2</month>
        <year>2013</year>
      </pub-date>
      <volume>8</volume>
      <fpage>29</fpage>
      <lpage>29</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>11</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>2</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2013 Pelemi&#x161; et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Pelemi&#x161; et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.cardiothoracicsurgery.org/content/8/1/29"/>
      <abstract>
        <sec>
          <title>Abstract</title>
          <p>Disseminated fungal infections are still rare conditions, mostly caused by <italic>Candida spp</italic>. during immunosuppression. Infection of immunocompetent individuals is uncommon. Endocarditis is a rare manifestation during candidaemia, mostly in patients with prosthetic valves. Affection of previously unaltered valves is uncommon.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We presented a case of a young, previously healthy female patient with endocarditis, caused by <italic>Candida parapsilosis</italic>. The initial symptom, fever, was present four months before hospital admittance. She was febrile without other symptoms and during observation in a local hospital. After her condition deteriorated, she was transferred to the Institute for infectious and tropical diseases, Belgrade. Clinical findings on admission include petechial skin rash and moderate hepatosplenomegaly. Newly developed systolic murmur was noted, and <italic>Candida parapsilosis</italic> was isolated in multiple blood cultures. Echocardiography revealed 15&#x2009;&#xD7;&#x2009;14&#xA0;mm vegetations on the right aortic vellum.</p>
          <p>She was treated with antifungal drugs (fluconasole, liposomal amphotericin B), and the affected valve was successfully replaced. The same strain of <italic>Candida parapsilosis</italic> was isolated from the intraoperative material of the valve.</p>
          <p>There were no markers of immunosuppression or other conditions which could affect the immune system.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>After a prolonged period of treatment she was successfully cured, and she received a long-term intermittent suppressive fluconasole therapy for the time being.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Native valve</kwd>
        <kwd>Antifungal therapy</kwd>
        <kwd>Post surgical treatment</kwd>
        <kwd>Candidaemia</kwd>
        <kwd>Candida endocarditis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Although disseminated fungal infections are more common today than before, they still remain rare conditions, mostly caused by <italic>Candida spp</italic>. <italic>Candida parapsilosis</italic> and <italic>Candida tropicalis</italic> are the most common causes in Europe [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Risk factors include immunosuppression (HIV, neutropenia, transplants, solid tumors), but infection of immunocompetent individuals is uncommon [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. Candidaemia has a significant mortality rate, up to 44% [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>Endocarditis is present in 5-25% of patients with candidaemia, mostly in patients with prosthetic valves [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Affection of previously unaltered heart valves is uncommon. During the past 20&#xA0;years, there have been only three cases reported in Sweden [<xref ref-type="bibr" rid="B4">4</xref>]. Other authors also refer to <italic>Candida</italic> endocarditis as an extremely rare occurrence in patients with normal native cardiac valves [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>].</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>We will present a case report of a previously healthy twenty-three year old Caucasian female patient, from a higher social-culture level, living in Belgrade suburbs. She had a negative history data to preexisting diseases, drug use or any underlining conditions.</p>
      <p>First symptom-fever, presented four months before hospital admittance, was treated with third generation cephalosporin (ceftriaxone 2,0 gr daily i.v.) and resolved within 5&#xA0;days. During the next month she was febrile without other symptoms. During that time the patient was observed in a local hospital, until her condition deteriorated - with anemia, leucopenia and petechial skin rash, and she was transferred to the Institute for Infectious and Tropical Diseases, Belgrade, Clinical Centre of Serbia. Clinical findings on admission included discreet petechial skin rash, moderate hepatosplenomegaly, whereas other systems were unaffected, including normal heart sounds. Laboratory tests showed moderate elevation of erythrocyte sedimentation rate, intermediary anemia and leucopenia, with elevated C-reactive protein. (Table&#xA0;<xref ref-type="table" rid="T1">1</xref>) <italic>Candida parapsilosis</italic>- sensitive to all systemic antifungal drugs was isolated in multiple blood cultures. The initial treatment included IV fluconazole 200&#xA0;mg/12&#xA0;h. During the third day of therapy, a newly developed systolic murmur was noted, presenting an indication for echocardiography. The patient was afebrile starting from that moment.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Laboratory results during course of illness, and follow-up</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">
                <bold>&#x2003; Analysis*</bold>
              </th>
              <th align="center">
                <bold>Admission day</bold>
              </th>
              <th align="center">
                <bold>Day 15</bold>
              </th>
              <th align="center">
                <bold>Day 30 (preoperatively)</bold>
              </th>
              <th align="center">
                <bold>Day 40 (8&#xA0;days after operation)</bold>
              </th>
              <th align="center">
                <bold>Discharge day</bold>
              </th>
              <th align="center">
                <bold>After 3&#xA0;year follow-up</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">SE (mm/hour)<hr/></td>
              <td align="center" valign="bottom">54<hr/></td>
              <td align="center" valign="bottom">50<hr/></td>
              <td align="center" valign="bottom">48<hr/></td>
              <td align="center" valign="bottom">36<hr/></td>
              <td align="center" valign="bottom">18<hr/></td>
              <td align="center" valign="bottom">2<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">HgB (gr/l)<hr/></td>
              <td align="center" valign="bottom">72<hr/></td>
              <td align="center" valign="bottom">105<hr/></td>
              <td align="center" valign="bottom">126<hr/></td>
              <td align="center" valign="bottom">117<hr/></td>
              <td align="center" valign="bottom">146<hr/></td>
              <td align="center" valign="bottom">140<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Er x10<sup>12</sup>/l<hr/></td>
              <td align="center" valign="bottom">2,71<hr/></td>
              <td align="center" valign="bottom">3,21<hr/></td>
              <td align="center" valign="bottom">3,66<hr/></td>
              <td align="center" valign="bottom">3,82<hr/></td>
              <td align="center" valign="bottom">4,12<hr/></td>
              <td align="center" valign="bottom">4,08<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Le x10<sup>9</sup>/l<hr/></td>
              <td align="center" valign="bottom">3,7<hr/></td>
              <td align="center" valign="bottom">3,1<hr/></td>
              <td align="center" valign="bottom">4,0<hr/></td>
              <td align="center" valign="bottom">6,5<hr/></td>
              <td align="center" valign="bottom">6,2<hr/></td>
              <td align="center" valign="bottom">5,6<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Tr x10<sup>9</sup>/l<hr/></td>
              <td align="center" valign="bottom">218<hr/></td>
              <td align="center" valign="bottom">317<hr/></td>
              <td align="center" valign="bottom">298<hr/></td>
              <td align="center" valign="bottom">321<hr/></td>
              <td align="center" valign="bottom">251<hr/></td>
              <td align="center" valign="bottom">253<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">fibrinogen (gr/l)<hr/></td>
              <td align="center" valign="bottom">2,2<hr/></td>
              <td align="center" valign="bottom">4,1<hr/></td>
              <td align="center" valign="bottom">4,4<hr/></td>
              <td align="center" valign="bottom">4,8<hr/></td>
              <td align="center" valign="bottom">2,4<hr/></td>
              <td align="center" valign="bottom">2,6<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">CRP (mg/l)<hr/></td>
              <td align="center" valign="bottom">38<hr/></td>
              <td align="center" valign="bottom">22<hr/></td>
              <td align="center" valign="bottom">28<hr/></td>
              <td align="center" valign="bottom">20<hr/></td>
              <td align="center" valign="bottom">4<hr/></td>
              <td align="center" valign="bottom">2<hr/></td>
            </tr>
            <tr>
              <td align="left">PT (sec)</td>
              <td align="center">14,5</td>
              <td align="center">13,2</td>
              <td align="center">12,9</td>
              <td align="center">16,8</td>
              <td align="center">17,8</td>
              <td align="center">18,9</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>Legend:</p>
          <p>*SE- erythrocytes sedimentation rate during first hour, HgB &#x2013; hemoglobin, Er &#x2013; ery throcytes, Le &#x2013; leucocytes, Tr &#x2013; thrombocytes, CRP &#x2013; C-reactive protein, PT &#x2013; prothrombine time.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>Echocardiography revealed 15&#x2009;&#xD7;&#x2009;14&#xA0;mm vegetations on the right aortic vellum. (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>) As Candida endocarditis usually appears in immunosuppressive patients as well as in patients with prosthetic valves, extensive clinical investigation was performed, to uncover any possible cause of immunosuppression. During a four-week period, all possible infectious agents were tested, including HIV, HBV, HCV, EBV, <italic>Leischmania</italic> and tuberculosis. Normal absolute count and ratio of CD4, CD2, CD3 and CD8 lymphocytes was noted, as well as normal concentration of immunoglobulines and sufficient immunological functions. There were no markers of autoimmune diseases which could affect the immune system. Hematological investigation was performed, as well as abdominal and chest CT, so the possible presence of solid tumors was excluded. A "10-panel urine screen" drug test was negative. During investigation, the patient was treated with fluconazole (200&#xA0;mg/12&#xA0;h, i.v.). Control echocardiography showed progressive enlargement of vegetations, spreading to the other vellum, so the treatment was continued with liposomal amphotericin B intravenously, 50&#xA0;mg daily. Since the transoesophageal echocardiography showed that after two weeks of new treatment there were two additional vegetations affecting vellums (17&#x2009;&#xD7;&#x2009;6&#xA0;mm and 12&#x2009;&#xD7;&#x2009;3&#xA0;mm), it was necessary to replace the affected heart valve. Control blood cultures, repeated daily from the fifth day of hospitalization (patient was afebrile), were sterile. Preoperatively, patient was treated with fluconazole for 38&#xA0;days, and liposomal amphotericin B for 15&#xA0;days. The affected valve (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>) was successfully replaced, and the same strain of <italic>Candida parapsilosis</italic> was isolated from intraoperative material of the valve.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Transthoracal echocardiografy in longitudinal and apical 4 chamber view vegetations on the aortic valves.</p>
        </caption>
        <graphic xlink:href="1749-8090-8-29-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Intraoperaive vegetation findings - aortic valve.</p>
        </caption>
        <graphic xlink:href="1749-8090-8-29-2"/>
      </fig>
      <p>Further conservative antifungal therapy was administered after operation, until laboratory findings were normalized, five months later. During this period the patient was treated with liposomal amphotericin B for 36&#xA0;days, IV in the daily dose of 50&#xA0;mg. For the rest of the period she was treated with fluconazole IV 200&#xA0;mg in the dose intervals of 12&#xA0;hours (approximately four months). During the whole period, no side-effects were observed.</p>
      <p>During the 3&#xA0;year follow-up, there were no other pathological developments, and the patient has been physically active and working.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>This report presents a rare disease progress in a young and previously healthy person, without any predisposing conditions - no immunodeficiency or previous valve defect [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. In spite of intensive systemic antifungal therapy, which is recommended [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>] there was no improvement, so the operative valve replacement was necessary, which has also been reported in other cases [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B7">7</xref>].</p>
      <p>After the patient was discharged from the hospital, she received a long-term intermittent suppressive fluconasole therapy. There is some difference in opinion concerning the time length of this therapy, including possibility of life-long treatment [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. During the three year follow-up, our patient has been taking 200&#xA0;mg of fluconasole twice a week with complete recovery and no other physical complaints.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>Although rare, Candida endocarditis in previously healthy patients, with no clear risk factors, is possible. During blood cultivation, one should always look for fungus. Candida endocarditis therapy is a combination of antifungal drugs and surgery, and the use of drugs is long-lasting.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>PM was the primary treating physician and is responsible for the treatment; SG participated in the treatment of patients and manuscript preparation; LL participated in the treatment of patients and manuscript preparation; MS was the main treating cardiologist who was constantly monitoring the patient; MI assisted in the treatment and monitoring of the patient and helped to draft the manuscript; KM assisted in the treatment and monitoring of the patient and helped to draft the manuscript; PS assisted in the treatment and monitoring of the patient and helped to draft manuscript; NM was the chief cardiologist responsible for echocardiogaphy and preoperative preparation; PM was the clinical pharmacologist responsible for the selection of antifungal drugs and their combination, as well as for the monitoring of adverse effects. All authors read and approved the final form manuscript.</p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgement</title>
      <p>The Authors wish to acknowledge Milica Jovanovic MD, PhD, microbiologist, who did an excellent job of identifying the causative agent.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Marchetti</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Bille</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fluckiger</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Eggiman</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ruef</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Garbino</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Calandra</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Glausser</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Tauber</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Pittet</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000</article-title>
          <source>Clin Infect Dis</source>
          <year>2004</year>
          <volume>38</volume>
          <fpage>311</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="doi">10.1086/380637</pub-id>
          <pub-id pub-id-type="pmid">14727199</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pfaller</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Diekema</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>RN</given-names>
          </name>
          <name>
            <surname>Sader</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Fluit</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Hollis</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Messer</surname>
            <given-names>SA</given-names>
          </name>
          <collab>and SENTRY Participant Group</collab>
          <article-title>International surveillance of bloodstream infections due to <italic>Candida</italic> species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program</article-title>
          <source>J Clin Microbiol</source>
          <year>2001</year>
          <volume>39</volume>
          <fpage>3254</fpage>
          <lpage>3259</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.39.9.3254-3259.2001</pub-id>
          <pub-id pub-id-type="pmid">11526159</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Almirante</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Rodr&#xED;guez</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>BJ</given-names>
          </name>
          <article-title>Epidemiology and Predictors of Mortality in Cases of <italic>Candida</italic> Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003</article-title>
          <source>J Clin Microbiol</source>
          <year>2005</year>
          <volume>43</volume>
          <issue>4</issue>
          <fpage>1829</fpage>
          <lpage>1835</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.43.4.1829-1835.2005</pub-id>
          <pub-id pub-id-type="pmid">15815004</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hogevik</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Alestig</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Fungal endocarditis &#x2013; a report on seven cases and a brief review</article-title>
          <source>Infection</source>
          <year>1996</year>
          <volume>24</volume>
          <fpage>17</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01780644</pub-id>
          <pub-id pub-id-type="pmid">8852457</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Branco</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Pitta</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Bernardes</surname>
            <given-names>L</given-names>
          </name>
          <article-title>A review of infectious endocarditis due to Candida [Abstract]</article-title>
          <source>Rev Port Cardiol</source>
          <year>1997</year>
          <volume>16</volume>
          <fpage>967</fpage>
          <lpage>974</lpage>
          <pub-id pub-id-type="pmid">9522617</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gullu</surname>
            <given-names>AU</given-names>
          </name>
          <name>
            <surname>Akcar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Arnaz</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Candida parapsilosis tricuspid native valve endocarditis: 3-year follow-up after surgical treatment</article-title>
          <source>Interact Cardiovasc Thorac Surg</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>513</fpage>
          <lpage>514</lpage>
          <pub-id pub-id-type="doi">10.1510/icvts.2007.173435</pub-id>
          <pub-id pub-id-type="pmid">18296475</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kan</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>PY</given-names>
          </name>
          <article-title>Native-valve endocarditis due to <italic>Candida parapsilosis</italic></article-title>
          <source>Interact Cardiovasc Thorac Surg</source>
          <year>2002</year>
          <volume>1</volume>
          <fpage>66</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="doi">10.1016/S1569-9293(02)00017-8</pub-id>
          <pub-id pub-id-type="pmid">17669962</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zedtwitz-Liebenstein</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gabriel</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Willinger</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Prosthetic valve endocarditis due to Candida tropicalis complicated by multiple pseudoaneurysms</article-title>
          <source>Infection</source>
          <year>2001</year>
          <volume>29</volume>
          <fpage>177</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="doi">10.1007/s15010-001-9170-9</pub-id>
          <pub-id pub-id-type="pmid">11440392</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chim</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Yuen</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Yuen</surname>
            <given-names>KY</given-names>
          </name>
          <article-title>Fungal endocarditis in bone marrow transplantation: case report and review of literature</article-title>
          <source>J Infect</source>
          <year>1998</year>
          <volume>37</volume>
          <fpage>287</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="doi">10.1016/S0163-4453(98)92169-7</pub-id>
          <pub-id pub-id-type="pmid">9892534</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
